A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response

Signal Transduct Target Ther. 2021 Sep 1;6(1):331. doi: 10.1038/s41392-021-00742-w.

Abstract

The recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of ongoing global pandemic of COVID-19, may trigger immunosuppression in the early stage and overactive immune response in the late stage of infection; However, the underlying mechanisms are not well understood. Here we demonstrated that the SARS-CoV-2 nucleocapsid (N) protein dually regulated innate immune responses, i.e., the low-dose N protein suppressed type I interferon (IFN-I) signaling and inflammatory cytokines, whereas high-dose N protein promoted IFN-I signaling and inflammatory cytokines. Mechanistically, the SARS-CoV-2 N protein dually regulated the phosphorylation and nuclear translocation of IRF3, STAT1, and STAT2. Additionally, low-dose N protein combined with TRIM25 could suppress the ubiquitination and activation of retinoic acid-inducible gene I (RIG-I). Our findings revealed a regulatory mechanism of innate immune responses by the SARS-CoV-2 N protein, which would contribute to understanding the pathogenesis of SARS-CoV-2 and other SARS-like coronaviruses, and development of more effective strategies for controlling COVID-19.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • COVID-19 / immunology*
  • COVID-19 / pathology
  • Caco-2 Cells
  • Coronavirus Nucleocapsid Proteins / immunology*
  • HEK293 Cells
  • Hep G2 Cells
  • Humans
  • Immunity, Innate*
  • Interferon Type I / immunology
  • Phosphoproteins / immunology
  • SARS-CoV-2 / immunology*
  • Signal Transduction / immunology*

Substances

  • Coronavirus Nucleocapsid Proteins
  • Interferon Type I
  • Phosphoproteins
  • nucleocapsid phosphoprotein, SARS-CoV-2